Traws Pharma, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2012 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Traws Pharma, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2012 to Q4 2023.
  • Traws Pharma, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $174M, a 2.44% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $174M +$4.16M +2.44% Dec 31, 2023 10-K 2024-04-01
Q4 2022 $170M -$3.72M -2.14% Dec 31, 2022 10-K 2024-04-01
Q4 2021 $174M +$5.51M +3.27% Dec 31, 2021 10-K 2023-03-30
Q4 2020 $168M +$7.32M +4.55% Dec 31, 2020 10-K 2022-03-21
Q4 2019 $161M +$16.7M +11.5% Dec 31, 2019 10-K 2021-03-18
Q4 2018 $144M $0 0% Dec 31, 2018 10-K 2020-03-27
Q4 2017 $144M -$13.4M -8.51% Dec 31, 2017 10-K 2019-04-01
Q4 2016 $158M +$8.74M +5.86% Dec 31, 2016 10-K 2018-03-16
Q4 2015 $149M +$17.1M +13% Dec 31, 2015 10-K 2017-03-29
Q4 2014 $132M +$38.6M +41.4% Dec 31, 2014 10-K 2016-03-28
Q4 2013 $93.3M +$38M +68.7% Dec 31, 2013 10-K 2015-03-30
Q4 2012 $55.3M Dec 31, 2012 10-K 2014-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.